Traveling the Vitamin B₁₂ Pathway: Oral Delivery of Protein and Peptide Drugs

Oral routes of administration for therapeutic peptides and proteins face two major barriers: proteolytic degradation in the stomach and an inadequate absorption mechanism for polypeptides within the intestinal lumen. As a result, peptide-based therapeutics are administered by injection, a painful pr...

Full description

Saved in:
Bibliographic Details
Published inAngewandte Chemie (International ed.) Vol. 48; no. 6; pp. 1022 - 1028
Main Authors Petrus, Amanda K, Fairchild, Timothy J, Doyle, Robert P
Format Journal Article
LanguageEnglish
Published Weinheim Wiley-VCH Verlag 26.01.2009
WILEY-VCH Verlag
WILEY‐VCH Verlag
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Oral routes of administration for therapeutic peptides and proteins face two major barriers: proteolytic degradation in the stomach and an inadequate absorption mechanism for polypeptides within the intestinal lumen. As a result, peptide-based therapeutics are administered by injection, a painful process associated with lower patient compliance. The development of a means of overcoming these two major obstacles and enabling the successful delivery of peptide therapeutics by the oral route of administration has therefore been the target of extensive scientific endeavor. This Minireview focuses on oral peptide/protein delivery by the dietary uptake pathway for vitamin B₁₂. Recent progress in this field includes the delivery of erythropoietin, granulocyte-colony-stimulating factor, luteinizing-hormone-releasing hormone, and insulin.
Bibliography:http://dx.doi.org/10.1002/anie.200800865
istex:065CDA5236645F0E94AC33B0F56BD169FF6F5C18
ArticleID:ANIE200800865
ark:/67375/WNG-57L72S34-G
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1433-7851
1521-3773
DOI:10.1002/anie.200800865